Tharimmune Inc Forgn. Eq (THAR)

Name: Tharimmune Inc Forgn. Eq (THAR) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Tharimmune Inc Forgn. Eq (THAR)

Stock Card

$3.31

$-0.20 (-5.70%)

As on 21-Apr-2026 09:30EDT

Market cap

$187 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

P/B Ratio

0.5

Div. Yield

0 %

Tharimmune Inc Forgn. Eq (THAR) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 3.31 High: 3.58

52 Week Range

Low: 1.05 High: 9.08

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-2.3 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

-6.3
Debt to Equity

0
Book Value

$--
EPS

$-2.1
Face value

--
Shares outstanding

39,529,847

Years Aggregate

CFO

$--

EBITDA

$--

Net Profit

$--

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Tharimmune Inc Forgn. Eq (THAR)	9.2	-0.5	13.4	192.9	-78.6	--	--
BSE Sensex^*	-9.1	-1.2	2.9	-3.6	5.7	6.2	10.5
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 21-Apr-2026 | *As on 31-Aug-2026 | #As on 26-Oct-2023

Company	2025	2024
Tharimmune Inc Forgn. Eq (THAR)	49.3	-73.1
S&P Small-Cap 600	4.0	7.0
BSE Sensex	9.1	8.1

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Tharimmune Inc Forgn. Eq (THAR)	3.3	187.4	0.0	-80.7	--	-33.9	--	0.5
Day One Biopharmaceuticals Inc (DAWN)	21.5	2,224.8	158.2	-107.3	-80.8	-22.7	--	5.0

Shareholding Pattern

View Details

About Tharimmune Inc Forgn. Eq (THAR)

Tharimmune, Inc. focuses on leveraging Canton Coin and supporting the Canton network to advance institutional blockchain adoption and the digitization of financial markets. It is also involved in the clinical-stage biotech research and development... activities. The company was formerly known as Hillstream BioPharma, Inc. and changed its name to Tharimmune, Inc. in September 2023. Tharimmune, Inc. was founded in 2017 and is based in Red Bank, New Jersey. Read more

President, Chairman & CEO

Mr. Randy D. Milby MBA
President, Chairman & CEO

Mr. Randy D. Milby MBA
Headquarters

Red Bank, NJ
Website

https://www.tharimmune.com

FAQs for Tharimmune Inc Forgn. Eq (THAR)

What is the current share price of Tharimmune Inc Forgn Eq (THAR) Today?

The share price of Tharimmune Inc Forgn Eq (THAR) is $3.31 (NASDAQ) as of 21-Apr-2026 09:30 EDT. Tharimmune Inc Forgn Eq (THAR) has given a return of -78.59% in the last 3 years.

What is the current PB & PE ratio of Tharimmune Inc Forgn Eq (THAR)?

Since, TTM earnings of Tharimmune Inc Forgn Eq (THAR) is negative, P/E ratio is not available.
The P/B ratio of Tharimmune Inc Forgn Eq (THAR) is 0.50 times as on 21-Apr-2026, a 90 discount to its peers’ median range of 5.18 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2025	-2.70	0.24
2024	-0.33	3.06
2023	-0.04	0.04
2022	0.00	0.00
2021	--	--

What is the 52 Week High and Low of Tharimmune Inc Forgn Eq (THAR)?

The 52-week high and low of Tharimmune Inc Forgn Eq (THAR) are Rs 9.08 and Rs 1.05 as of 01-Sep-2026.

What is the market cap of Tharimmune Inc Forgn Eq (THAR)?

Tharimmune Inc Forgn Eq (THAR) has a market capitalisation of $ 187 Mln as on 21-Apr-2026. As per SEBI classification, it is a Small Cap company.

Should I invest in Tharimmune Inc Forgn Eq (THAR)?

Before investing in Tharimmune Inc Forgn Eq (THAR), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.